Related Experiment Video
Updated: Oct 20, 2025

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
Published on: January 12, 2020
KCTD15 deregulation is associated with alterations of the NF-κB signaling in both pathological and physiological
Giovanni Smaldone1, Luigi Coppola1, Katia Pane1
1IRCCS SDN, Via E. Gianturco 113, 80143, Naples, Italy.
Abstract:
Like other KCTD proteins, KCTD15 is involved in important albeit distinct biological processes as cancer, neural crest formation, and obesity. Here, we characterized the role of KCTD15 in different physiological/pathological states to gain insights into its diversified function(s). The silencing of KCTD15 in MLL-rearranged leukemia models induced attenuation of the NF-κB pathway associated with a downregulation of pIKK-β and pIKB-α. Conversely, the activation of peripheral blood T cells upon PMA/ionomycin stimulation remarkably upregulated KCTD15 and, simultaneously, pIKK-β and pIKB-α. Moreover, a significant upregulation of KCTD15 was also observed in CD34 hematopoietic stem/progenitor cells where the NF-κB pathway is physiologically activated. The association between KCTD15 upregulation and increased NF-κB signaling was confirmed by luciferase assay as well as KCTD15 and IKK-β proximity ligation and immunoprecipitation experiments. The observed upregulation of IKK-β by KCTD15 provides a novel and intriguing interpretative key for understanding the protein function in a wide class of physiological/pathological conditions ranging from neuronal development to cancer and obesity/diabetes.
Insights
KCTD15 protein influences the NF-κB pathway, impacting conditions from leukemia to obesity. Its upregulation correlates with increased NF-κB signaling, offering new insights into diverse biological roles.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Cancer Research
Background:
- KCTD15, a member of the KCTD protein family, participates in critical biological processes including cancer, neural crest formation, and obesity.
- Understanding KCTD15's diverse functions across various physiological and pathological states is crucial.
Purpose of the Study:
- To investigate the role of KCTD15 in different physiological and pathological conditions.
- To elucidate the relationship between KCTD15 and the NF-κB signaling pathway.
Main Methods:
- Silencing KCTD15 in MLL-rearranged leukemia models.
- Stimulating peripheral blood T cells and analyzing CD34 hematopoietic stem/progenitor cells.
- Employing luciferase assays, proximity ligation, and immunoprecipitation experiments.
Main Results:
- KCTD15 silencing attenuated the NF-κB pathway in leukemia models, downregulating pIKK-β and pIKB-α.
- T cell activation and CD34+ cell activation upregulated KCTD15, pIKK-β, and pIKB-α.
- Experiments confirmed the association between KCTD15 upregulation and enhanced NF-κB signaling, with KCTD15 upregulating IKK-β.
Conclusions:
- KCTD15 plays a significant role in regulating the NF-κB pathway.
- The upregulation of IKK-β by KCTD15 provides a novel mechanism for its function in diverse conditions.
- KCTD15's involvement spans neuronal development, cancer, and metabolic disorders like obesity and diabetes.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Co-activators and Co-repressors
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulation of the Unfolded Protein Response
The Extrinsic Apoptotic Pathway

